CTXR
Citius Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.59
−2.38%Next report
Analyst consensus
- Next report date
- Dec 22, 2026
- EPS estimate
- -$0.41
- Revenue estimate
- $2.9M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.34
- EPS estimate
- -$0.36
- Revenue actual
- $1.5M
- Revenue estimate
- $5.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -137.4%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 22, 2026